SynthesisEating and weight disorders : EWD2025

The impact of glucagon-like peptide-1 (GLP-1) agonists in the treatment of eating disorders: a systematic review and meta-analysis.

Hanieh Radkhah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.